CAPLIN POINT LABORATORIES LTD. - 524742 - Update on board meeting
The Board Meeting to be held on 24/05/2023 has been revised to 27/05/2023 The Board Meeting to be held on 24/05/2023 has been revised to 27/05/202322-05-2023
22-05-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Conference call with the analysts / fund houses/ investors will be held on Wednesday, May 24, 2023, at 16.00 hrs. (IST) to discuss the financial performance of the Company for the quarter and year ended March 31, 202318-05-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
This is to inform that mentioned share certificate has been reported as lost by the shareholders of the Company.17-05-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Board Meeting Intimation for Board Meeting Intimation For Considering And Approving Financial Results And Declaring Dividend
CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2023 ,inter alia, to consider and approve 1. Considering and Approving Quarterly and yearly Audited Financial Results. 2. Declaration of Interim Dividend.13-05-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Cessation
In furtherance to our intimation dated May 08, 2015 on the re-appointment of Mr. R Viswanathan as an Independent Director of the Company for a second term of five years with effect from May 12, 2018, we would like to inform you that his term as an Independent Director expired on the close of business hours of May 12, 2023 and thereby he ceases to continue as an Independent Director.13-05-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
This is to inform that mentioned share certificate has been reported as lost by the shareholders of the Company13-05-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release regarding grant of United States Food and Drug Administration (USFDA) approval for the Abbreviated New Drug Application (ANDA) Ketorolac Tromethamine Injection USP to our Subsidiary Caplin Steriles Limited12-05-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
This is to inform that mentioned share certificate has been reported as lost by the shareholder of the Company.11-05-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
This is to inform that mentioned share certificate has been reported as lost by the shareholder of the Company.05-05-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
This is to inform that below mentioned share certificate has been reported as lost by the shareholder of the Company.02-05-2023